Authors: Rodrigues, F.A.R.; Oliveira, A.C.A.; Cavalcanti, B.C.; Costa, P.M.; Pessoa, C.O.; Pinheiro, A.C.; De Souza, M.V.N.
Source: European Chemical Bulletin, v. 3, p. 555-558, 2014.
Publisher: Deuton-X Ltd. by support of Research Centre for Natural Sciences, Hungarian Academy of Sciences.
Abstract
A series of fifty-four commercial aldehydes have been synthesized and evaluated for their activity against peripheral blood mononuclear cells (PBMC) and four human cancer cell lines, exhibiting potent citotoxicity (IC50 ranging from 0.36 to 4.75 μg/mL). The structure-activity relationship (SAR) analysis indicated that the number, the positions and the type of substituents attached into the aromatic and heteroaromatic ring are critical for the biological activity. The aldehydes 24, 26, 48 and 49 displayed a potent citotoxicity activity compared to the reference drug doxorubicin being, therefore, this discovery important for the rational design of new compounds against cancer.
Keywords: cytotoxicity, substituted aldehydes, drugs, SAR, glioblastoma, ovary, colon Document Type: Research Article DOI: None Publication date: 21 de Abril de 2014
